Sven Turkalj

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Protocol for high-quality RNA sequencing, cell surface protein analysis, and genotyping in single cells using TARGET-seq.

Protocol for high-quality RNA sequencing, cell surface protein analysis, and genotyping in single cells using TARGET-seq.

Journal: STAR protocols
Published: February 25, 2025

Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.

Rapid clonal selection within early hematopoietic cell compartments presages the outcome of ivosidenib combination therapy.

Journal: Blood
Published: December 19, 2024

Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy.

Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy.

Journal: Blood
Published: December 19, 2024

Human haematopoietic stem cells remember inflammatory stress.

Human haematopoietic stem cells remember inflammatory stress.

Journal: Nature
Published: September 18, 2024

Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved.

Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved.

Journal: Science immunology
Published: August 23, 2024

A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cells.

A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cells.

Journal: STAR protocols
Published: August 11, 2023

Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.

Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.

Journal: Cell stem cell
Published: June 25, 2023

An Overview of Targeted Therapies in Acute Myeloid Leukemia.

An Overview of Targeted Therapies in Acute Myeloid Leukemia.

Journal: HemaSphere
Published: April 18, 2023

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.

Journal: Blood cancer discovery
Published: December 20, 2022

GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells.

GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells.

Journal: Cell stem cell
Published: October 04, 2022

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.

Journal: Cancers
Published: May 04, 2020

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.

Journal: Leukemia
Published: October 10, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026